1.0Andreas Kalckerhttps://andreaskalcker.com/en/andreasKalckerWqhttps://andreaskalcker.com/en/author/andreaskalckerwq/rich600338<blockquote class="wp-embedded-content" data-secret="63OqPZk7X7"><a href="https://andreaskalcker.com/en/medical-protocols/">Medical protocols</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://andreaskalcker.com/en/medical-protocols/embed/#?secret=63OqPZk7X7" width="600" height="338" title="“Medical protocols” — Andreas Kalcker" data-secret="63OqPZk7X7" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://andreaskalcker.com/wp-includes/js/wp-embed.min.js </script> Protocol soon available. Protocol Y CDI injection Intravenous chlorine dioxide (only for physicians under Helsinki WMA Article 37)   Standard dose: 5 ml of CDS (0.3% = 3000 ppm) per 500 ml of 0.9% NaCl.   This type of treatment is strictly reserved for professional physicians in the investigative health sector. The patient must have signed a prior consent to comply with the regulations of § 37 of the Helsinki Protocol (AMA).    CDI = 0.9% NaCl 0.9% saline + chlorine dioxide (preferably by electrolisis and microfiltered ) in aqueous solution. It is not used intramuscularly.    The goal is to achieve sufficient saturation, since CDS is consumed within two hours without leaving measurable residues as it decomposes in a short time to common salt and oxygen. Intravenous use is mainly indicated for acute cases of hypoxia, sepsis and histamine reactions. For chronic disease, protocols C and E are primarily applied first, and the intravenous route can be used as a adicional stimulus to reach deeper tissue. A. Subcutaneous use: A simple way to address local problems is by subcutaneous injection of papules. The protocol consists of injecting several subcutaneous papules with a concentration of 50 ppm (=0.005%) and pH 7.6 in a volume of 2-5 ml of chlorine dioxide solution (CDI) near the affected area. As a gas dissolved in water, it is easily distributed in the affected area. It can be repeated if necessary.   Note: If the pH is below 7.4, a burning sensation might be experienced. Therefore, it is compensated by tamponade with an 8% bicarbonate solution, adding approximately 1-2 ml to a 0.9% NaCl saline bag. Subsequently, the pH is checked with a calibrated digital meter.   Emergency Tip: If a pH meter is not available, the pH can be checked before injecting by placing a few drops of the CDI (saline with prepared CDS) in the tear duct and blinking a little. The solution should be pleasant, like an eye drop. Otherwise, it may be too concentrated or have a low pH. B. Intravenous use: The patient should have followed an oral C or rectal E protocol at least 7 days before starting this therapeutic approach (with exceptions, such as in acute cases) for best results and to ensure adequate saturation.   Catheterization is performed by placing peripheral lines with intravenous catheter (~18 or 20 gauge), changing arms at each infusion, and the number of infusions is decided according to the patient’s condition. Perform venous puncture gently avoiding hematomas.   Optionally and as recommended, venous blood gas analysis can be performed before and after to determine the patient’s pH, pCO2, pO2, BEecf, LAC and CREA and to determine the efficacy of the dose. Based on the patient’s plasma ionogram, environment, personal history and medical history, the use of physiologic solution without dextrose is determined based on availability. It is advisable to use isotonic NaCl (0.9%) or lactate-free Ringer’s solution.   Add 1 to 2 ml of concentrated CDS (0.3% = 3000 ppm) per 100 ml of isotonic NaCl (0.9%) saline. The standard dose is determined as 5 ml of Chlorine Dioxide Electrolyte (CDE) at 3000 ppm in 500 ml of saline solution over a 5-hour period as needed. The dose may be doubled, but should be administered more slowly to avoid burning sensation. In emergency cases, standard CDS can also be used. Electrolyte CDS is simply purer and does not contain any traces. To administer higher doses, the subclavicular route is used.   The pH of the infusion bag with the included solutions (CDE + saline) should preferably be pH 7.6, digitally measured and calibrated. To correct and reach the indicated pH range in case it is lower, it should be compensated with an 8% bicarbonate solution (HCO3). Typically 1-2 ml is used for a 500 ml bag of NaCl(0.9%) saline solution. This small amount does not override or neutralize the ClO2 content and avoids irritation or burning sensation of the veins. If a pH meter is not available, the pH can be checked before injecting by placing a few drops of the CDI (saline with prepared CDS) in the eye by blinking a little. The solution should be pleasant, like an eye drop. If it is not, this indicates that it is too concentrated or the pH is low.   The indicated oxygenating hydration with CDI is 500 ml to be administered over a period of >2-5 hours. The contents in the bag should be at room temperature and protected from direct sunlight (UV rays) which would eliminate its efficacy.   A continuous infusion pump (CIP) can be used for a precise and timely drip if necessary for hospitalized patients who require constant infusion due to their severity. It can also be applied subclavically without problems.   A second venous blood gas analysis can be performed to record post-IV status for documentation. Standard duration: 4 consecutive days in severe acute cases or 2 times per week in chronic cases and always accompanied by Protocol C20.   Adequate post-puncture compression is recommended to avoid bleeding. Saturation can continue with oral and/or rectal CDS two hours after IV application, Protocol C and/or Protocol E. In critically ill or intubated patients, it can be applied without prior oral dosing with a drip of 30 drops per minute with 10-15 ml of CDI (3000 ppm) in a 500 ml NaCl (0.9%) saline bag adjusted to pH 7.6 but preferably slow with administration between 6-8 hours. In subsequent practices, vary the site of application at different locations to avoid irritation or burning. C. Surgical Use: For surgical use, various concentrations are used: A.) For disinfecting wounds, preventing adhesions, cancer surgery and osteomyelitis The use of a 300-400 ppm solution in NaCl (0.9%) saline is used to disinfect wounds, prevent adhesions, perform cancer surgery and treat osteomyelitis.   This specific concentration of the solution has cleansing properties that promote 50% faster recovery without any infection in all known cases. In addition, its use has been observed to generate no reported toxic effects. An additional ... Read more